Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2019 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2019 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The role of Zeb1 in the pathogenesis of morbidly adherent placenta

Retraction in: /10.3892/mmr.2025.13493
  • Authors:
    • Na Li
    • Tian Yang
    • Wenqian Yu
    • Hao Liu
    • Chong Qiao
    • Caixia Liu
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2812-2822
    |
    Published online on: July 12, 2019
       https://doi.org/10.3892/mmr.2019.10490
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Zinc finger E‑box‑binding homeobox 1 (Zeb1) is a promoter of epithelial‑mesenchymal transformation, which may serve an important role in morbidly adherent placenta (MAP). In the present study, the protein expression levels of Zeb1 were examined in the placenta tissues of 60 patients, including 20 patients with placenta accreta (PA) and 20 patients with placenta previa without PA (UPA) and 20 patients in late pregnancy that delivered by cesarean section (normal). The expression levels of Zeb1, N‑cadherin, vascular endothelial growth factor (VEGF), Tumor necrosis factor‑related apoptosis‑inducing ligand‑receptor 2 (TRAIL‑R2), and tumor necrosis factor‑related apoptosis‑inducing ligand‑receptor 3 (TRAIL‑R3) were higher in PA tissues compared with in normal control tissues. The expression levels of E‑cadherin and TRAIL‑R2 were decreased in PA tissues compared with in normal control tissues. These findings indicated that Zeb1 may serve an important role in placental attachment, thus promoting the development of dangerous PA. Overexpression of Zeb1 may upregulate the expression levels of N‑cadherin, VEGF, TRAIL‑R3, cyclin D1 and Bcl‑2, and downregulate the expression levels of E‑cadherin and TRAIL‑R2. In addition, Zeb1 regulated the viability, apoptosis and migration of HTR‑8/SV neo cells and human umbilical vein endothelial cells by regulating the Akt pathway. In conclusion, these findings indicated that Zeb1 may promote placental implantation by activating the Akt signaling pathway, thus providing a theoretical basis for investigating the causes of MAP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Roziana R, Kamarul Azhar K, Lau JH, Aina MAA, Nadia R, Siti Nordiana A and Mohd Zulkifli K: Morbidly adherent placenta: One-year case series in a tertiary hospital. Med J Malaysia. 74:128–132. 2019.PubMed/NCBI

2 

Balachandar K and Inglis E: The management of severe pre-eclampsia and HELLP syndrome in a twin pregnancy with a known morbidly adherent placenta: A case report. Case Rep Womens Health. 22:e001142019. View Article : Google Scholar : PubMed/NCBI

3 

Bamber JH and Sobers S: The Need to Consider the Women's Perspective: Neuraxial anesthesia and cesarean delivery for morbidly adherent placenta. Anesth Analg. 128:e56–e57. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Lopes ES, Feitosa FEL, Brazil AV, de Castro JDV, da Costa JIF, Araujo Júnior E, Peixoto AB and Carvalho FHC: Assessment of sensitivity and specificity of ultrasound and magnetic resonance imaging in the diagnosis of placenta accreta. Rev Bras Ginecol Obstet. 41:17–23. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Furukawa S, Fujisaki M, Maki Y, Oohashi M, Doi K and Sameshima H: Manual removal of placenta in women having unpredictable adherent placenta. J Obstet Gynaecol Res. 45:141–147. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Katzman PJ, Blitman J and Metlay LA: Basal chronic villitis and disorders of the placental basal plate: A possible immunological link between hypertensive disorders of pregnancy and morbidly adherent placenta. Pediatr Dev Pathol. Jan 21–2019.(Epub ahead of print). doi: 10.1177/1093526619825708. View Article : Google Scholar

7 

Wang Y, Wu Z and Hu L: The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer (CRC). Eur J Pharmacol. 834:45–53. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Egger JV, Lane MV, Antonucci LA, Dedi B and Krucher NA: Dephosphorylation of the retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Cancer Biol Ther. 17:1197–1205. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H and McConkey BJ: The GRHL2/ZEB Feedback Loop-A Key Axis in the regulation of EMT in breast cancer. J Cell Biochem. 118:2559–2570. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Noman MZ, Janji B, Abdou A, Hasmim M, Terry S, Tan TZ, Mami-Chouaib F, Thiery JP and Chouaib S: The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200. Oncoimmunology. 6:e12634122017. View Article : Google Scholar : PubMed/NCBI

11 

Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, et al: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Rhodes LV, Tate CR, Segar HC, Burks HE, Phamduy TB, Hoang V, Elliott S, Gilliam D, Pounder FN, Anbalagan M, et al: Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Res Treat. 145:593–604. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Shu H, Chen H, Yang B, Chang Z, Xiong M and Chen W: Aberrant expression of E-cadherin and integrin β-1 in trophoblasts is associated with malignant gestational trophoblastic diseases. Int J Gynecol Cancer. 23:749–754. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Al-Khan A, Bulmer JN, Chantraine F, Chen CP, Chen Q, Collins S, Cotechini T, Fitzgerald JS, He M, Holland O, et al: IFPA Meeting 2012 Workshop Report III: Trophoblast deportation, gestational trophoblastic disease, placental insufficiency and fetal growth restriction, trophoblast over-invasion and accreta-related pathologies, placental thrombosis and fibrinolysis. Placenta. 34 (Suppl):S11–S16. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Wang Y, Jia L, Wang B, Diao S, Jia R and Shang J: MiR-495/IGF-1/AKT Signaling as a novel axis is involved in the Epithelial-to-Mesenchymal transition of oral squamous cell carcinoma. J Oral Maxillofac Surg. 77:1009–1021. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Hu T, Lu MN, Chen B, Tong J, Mao R, Li SS, Dai P, Tan YX and Xiyang YB: Electro-acupuncture-induced neuroprotection is associated with activation of the IGF-1/PI3K/Akt pathway following adjacent dorsal root ganglionectomies in rats. Int J Mol Med. 43:807–820. 2019.PubMed/NCBI

18 

Kuang WH, Dong ZQ, Tian LT and Li J: IGF-1 defends against chronic-stress induced depression in rat models of chronic unpredictable mild stress through the PI3K/Akt/FoxO3a pathway. Kaohsiung J Med Sci. 34:370–376. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Zhang Q, Zhou L, Guan Y, Cheng Y and Han X: BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop. Chem Biol Interact. 294:18–27. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Matsubara S: Balloon uterine tamponade device after peripartum hysterectomy for morbidly adherent placenta. Obstet Gynecol. 133:1882019. View Article : Google Scholar : PubMed/NCBI

21 

Shmakov RG, Vinitskiy AA, Chuprinin VD, Yarotskaya EL and Sukhikh GT: Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J Matern Fetal Neonatal Med. 32:2042–2048. 2019. View Article : Google Scholar : PubMed/NCBI

22 

Shin JO, Nakagawa E, Kim EJ, Cho KW, Lee JM, Cho SW and Jung HS: miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem Cell Biol. 137:459–470. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Kokkinos MI, Murthi P, Wafai R, Thompson EW and Newgreen DF: Cadherins in the human placenta-epithelial-mesenchymal transition (EMT) and placental development. Placenta. 31:747–755. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K and Hansson SR: Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta. 25:518–529. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Duzyj CM, Buhimschi IA, Motawea H, Laky CA, Cozzini G, Zhao G, Funai EF and Buhimschi CS: The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. Placenta. 36:645–651. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Incebiyik A, Kocarslan S, Camuzcuoglu A, Hilali NG, Incebiyik H and Camuzcuoglu H: Trophoblastic E-cadherin and TGF-beta expression in placenta percreta and normal pregnancies. J Matern Fetal Neonatal Med. 29:126–129. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Guimaraes GC, Alves LA, Betarelli RP, Guimarães CSO, Helmo FR, Pereira Júnior CD, Corrêa RRM and Zangeronimo MG: Expression of vascular endothelial growth factor (VEGF) and factor VIII in the gilt placenta and its relation to fetal development. Theriogenology. 92:63–68. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Klettner A, Kaya L, Flach J, Lassen J, Treumer F and Roider J: Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE. Mol Vis. 21:736–748. 2015.PubMed/NCBI

29 

Mathew S, Sundararaj S, Mamiya H and Banerjee I: Regulatory interactions maintaining self-renewal of human embryonic stem cells as revealed through a systems analysis of PI3K/AKT pathway. Bioinformatics. 30:2334–2342. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Lv WM, Zhao Y, Yang G, Dong SY, Zhang GH, Zhang Y, Li GZ and Cheng Y: Role of Ras, ERK, and Akt in glucocorticoid-induced differentiation of embryonic rat somatotropes in vitro. Mol Cell Biochem. 391:67–75. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Godoy-Parejo C, Deng C, Liu W and Chen G: Insulin stimulates PI3K/AKT and cell adhesion to promote the survival of individualized human embryonic stem cells. Stem Cells. Apr 25–2019.(Epub ahead of print). doi: 10.1002/stem.3026. View Article : Google Scholar : PubMed/NCBI

32 

Park JH and Han HJ: Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: Involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol. 297:C935–C944. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Tan Y, Xin X, Coffey FJ, Wiest DL, Dong LQ and Testa JR: Appl1 and Appl2 are expendable for mouse development but are essential for HGF-Induced akt activation and migration in mouse embryonic fibroblasts. J Cell Physiol. 231:1142–1150. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li N, Yang T, Yu W, Liu H, Qiao C and Liu C: The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493. Mol Med Rep 20: 2812-2822, 2019.
APA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., & Liu, C. (2019). The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493. Molecular Medicine Reports, 20, 2812-2822. https://doi.org/10.3892/mmr.2019.10490
MLA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493". Molecular Medicine Reports 20.3 (2019): 2812-2822.
Chicago
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493". Molecular Medicine Reports 20, no. 3 (2019): 2812-2822. https://doi.org/10.3892/mmr.2019.10490
Copy and paste a formatted citation
x
Spandidos Publications style
Li N, Yang T, Yu W, Liu H, Qiao C and Liu C: The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493. Mol Med Rep 20: 2812-2822, 2019.
APA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., & Liu, C. (2019). The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493. Molecular Medicine Reports, 20, 2812-2822. https://doi.org/10.3892/mmr.2019.10490
MLA
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493". Molecular Medicine Reports 20.3 (2019): 2812-2822.
Chicago
Li, N., Yang, T., Yu, W., Liu, H., Qiao, C., Liu, C."The role of Zeb1 in the pathogenesis of morbidly adherent placenta Retraction in /10.3892/mmr.2025.13493". Molecular Medicine Reports 20, no. 3 (2019): 2812-2822. https://doi.org/10.3892/mmr.2019.10490
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team